| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |